Mounjaro, on the other hand, contains sotagliflozin, a medication similar to a shield that blocks glucose absorption in the kidneys and intestines
Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide
Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 1 diabetes, irrespective of body mass index at baseline
Serious risks associated with using Quinine to prevent or treat nocturnal leg cramps
These are often temporary
So a bunch of different scientists started testing it in Petri dishes and in animals, and it turns out GLP-1 increases insulin release and lowers blood sugar and slows the rate the stomach empties out and makes people feel more full and eat less, exactly the things that could help treat type two diabetes